{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,4]],"date-time":"2026-10-04T02:51:52Z","timestamp":1791082312265,"version":"4.1.0"},"reference-count":11,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,11,9]],"date-time":"2022-11-09T00:00:00Z","timestamp":1667952000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["jaadcasereports.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["JAAD Case Reports"],"published-print":{"date-parts":[[2023,1]]},"DOI":"10.1016\/j.jdcr.2022.11.008","type":"journal-article","created":{"date-parts":[[2022,11,13]],"date-time":"2022-11-13T18:08:06Z","timestamp":1668362886000},"page":"27-30","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":18,"special_numbering":"C","title":["A case of Rowell syndrome with excellent improvement following anifrolumab"],"prefix":"10.1016","volume":"31","author":[{"given":"Chelsea","family":"Shope","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura","family":"Andrews","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Melissa","family":"Cunningham","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jessica","family":"Connett","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"4","key":"10.1016\/j.jdcr.2022.11.008_bib1","first-page":"40","article-title":"Rowell syndrome: a diagnostic challenge","volume":"13","author":"Gallo","year":"2020","journal-title":"J Clin Aesthet Dermatol"},{"issue":"4","key":"10.1016\/j.jdcr.2022.11.008_bib2","doi-asserted-by":"crossref","first-page":"608","DOI":"10.4103\/idoj.IDOJ_554_20","article-title":"Rowell's syndrome: a case report and literature overview","volume":"12","author":"Sethy","year":"2021","journal-title":"Indian Dermatol Online J"},{"issue":"15","key":"10.1016\/j.jdcr.2022.11.008_bib3","doi-asserted-by":"crossref","first-page":"1795","DOI":"10.1007\/s40265-021-01604-z","article-title":"Anifrolumab: first approval","volume":"81","author":"Deeks","year":"2021","journal-title":"Drugs"},{"issue":"2","key":"10.1016\/j.jdcr.2022.11.008_bib4","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1046\/j.1365-2230.1999.00422.x","article-title":"Rowell's syndrome","volume":"24","author":"Child","year":"1999","journal-title":"Clin Exp Dermatol"},{"issue":"Suppl 1","key":"10.1016\/j.jdcr.2022.11.008_bib5","doi-asserted-by":"crossref","first-page":"S33","DOI":"10.4103\/2229-5178.144526","article-title":"Rowell syndrome","volume":"5","author":"Bhat","year":"2014","journal-title":"Indian Dermatol Online J"},{"issue":"2","key":"10.1016\/j.jdcr.2022.11.008_bib6","doi-asserted-by":"crossref","DOI":"10.5070\/D3272052390","article-title":"Targetoid lesions in a patient with systemic lupus erythematosus","volume":"27","author":"Imtiaz","year":"2021","journal-title":"Dermatol Online J"},{"issue":"4","key":"10.1016\/j.jdcr.2022.11.008_bib7","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1111\/1756-185X.13817","article-title":"State-of-the-art treatment of systemic lupus erythematosus","volume":"23","author":"Tanaka","year":"2020","journal-title":"Int J Rheum Dis"},{"issue":"3","key":"10.1016\/j.jdcr.2022.11.008_bib8","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1016\/j.berh.2013.07.008","article-title":"Cutaneous lupus erythematosus: diagnosis and treatment","volume":"27","author":"Okon","year":"2013","journal-title":"Best Pract Res Clin Rheumatol"},{"issue":"8","key":"10.1016\/j.jdcr.2022.11.008_bib9","doi-asserted-by":"crossref","first-page":"1254","DOI":"10.1177\/09612033211014267","article-title":"Anifrolumab reduces flare rates in patients with moderate to severe systemic lupus erythematosus","volume":"30","author":"Furie","year":"2021","journal-title":"Lupus"},{"issue":"3","key":"10.1016\/j.jdcr.2022.11.008_bib10","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1056\/NEJMoa1912196","article-title":"Trial of anifrolumab in active systemic lupus erythematosus","volume":"382","author":"Morand","year":"2020","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jdcr.2022.11.008_bib11","doi-asserted-by":"crossref","first-page":"1998","DOI":"10.1111\/ced.15335","article-title":"Anifrolumab for treatment of refractory cutaneous lupus erythematosus","volume":"47","author":"Blum","year":"2022","journal-title":"Clin Exp Dermatol"}],"container-title":["JAAD Case Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2352512622005057?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2352512622005057?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,7]],"date-time":"2025-11-07T00:24:54Z","timestamp":1762475094000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2352512622005057"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,1]]},"references-count":11,"alternative-id":["S2352512622005057"],"URL":"https:\/\/doi.org\/10.1016\/j.jdcr.2022.11.008","relation":{},"ISSN":["2352-5126"],"issn-type":[{"value":"2352-5126","type":"print"}],"subject":[],"published":{"date-parts":[[2023,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A case of Rowell syndrome with excellent improvement following anifrolumab","name":"articletitle","label":"Article Title"},{"value":"JAAD Case Reports","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jdcr.2022.11.008","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Published by Elsevier on behalf of the American Academy of Dermatology, Inc. This is an open access..","name":"copyright","label":"Copyright"}]}}